What is the current stock price of Oxurion N.V. (OXUR.BR)?

As of the latest market data, Oxurion N.V. (OXUR.BR) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Oxurion N.V. (OXUR.BR) pay a dividend?

Based on current data, Oxurion N.V. does not have a confirmed active dividend policy.

What is the market cap of Oxurion N.V.?

The current market capitalization of Oxurion N.V. (OXUR.BR) is approximately unavailable.

OXUR.BR

Oxurion N.V.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2006-07-07

Beta

-0.04

Websitewww.oxurion.com↗